NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis
- PMID: 35220409
- PMCID: PMC8882174
- DOI: 10.1038/s41420-022-00887-9
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis
Abstract
Radiation-induced lung injury (RILI) is a common complication of radiotherapy for which no effective interventions are available. NVP-AUY922, a resorcinylic isoxazole amide drug, exhibits anti-inflammatory, immunomodulatory, and therapeutic effects against various types of cancers. In this study, we explore the role and underlying mechanisms of NVP-AUY922 in the treatment of RILI. We established a model of BEAS-2B cell injury and a mouse model of RILI. Cell proliferation, death, gross weight, and survival rates of mice, and histological parameters were assessed. Additionally, inflammation-related indices and indicators related to ferroptosis were evaluated. Furthermore, immunofluorescence and co-immunoprecipitation were used to determine the interaction between GPX4, LAMP-2A, and HSC70. NVP-AUY922 significantly ameliorated radiation-induced lung tissue damage, inflammatory cell infiltration, proinflammatory cytokine release, and lung epithelial BEAS-2B cell damage. NVP-AUY922 markedly limited the activation of ferroptosis, which is involved in RILI. Mechanistically, NVP-AUY922 prevented chaperone-mediated autophagy of the GPX4 pathway in vitro and in vivo, and the autophagy inhibitor Baf-A1 significantly increased the level of GPX4 and alleviated lung inflammation. NVP-AUY922 can alleviate RILI by inhibiting chaperone-mediated lysosomal degradation of GPX4, demonstrating its potential as a novel protective agent against RILI.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI.Cell Death Dis. 2021 Jan 11;12(1):65. doi: 10.1038/s41419-020-03362-4. Cell Death Dis. 2021. PMID: 33431801 Free PMC article.
-
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.Cancer Res. 2008 Apr 15;68(8):2850-60. doi: 10.1158/0008-5472.CAN-07-5256. Cancer Res. 2008. PMID: 18413753
-
Role of ferroptosis in the process of acute radiation-induced lung injury in mice.Biochem Biophys Res Commun. 2019 Nov 5;519(2):240-245. doi: 10.1016/j.bbrc.2019.08.165. Epub 2019 Sep 4. Biochem Biophys Res Commun. 2019. PMID: 31493867
-
Sphingolipids as a Novel Therapeutic Target in Radiation-Induced Lung Injury.Cell Biochem Biophys. 2021 Sep;79(3):509-516. doi: 10.1007/s12013-021-01022-8. Epub 2021 Aug 9. Cell Biochem Biophys. 2021. PMID: 34370281 Free PMC article. Review.
-
Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury.Front Oncol. 2023 Mar 8;13:966060. doi: 10.3389/fonc.2023.966060. eCollection 2023. Front Oncol. 2023. PMID: 36969016 Free PMC article. Review.
Cited by
-
Autophagy-dependent ferroptosis in infectious disease.J Transl Int Med. 2023 Dec 20;11(4):355-362. doi: 10.2478/jtim-2023-0099. eCollection 2023 Dec. J Transl Int Med. 2023. PMID: 38130644 Free PMC article.
-
Cooperation effects of radiation and ferroptosis on tumor suppression and radiation injury.Front Cell Dev Biol. 2022 Sep 13;10:951116. doi: 10.3389/fcell.2022.951116. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36176274 Free PMC article. Review.
-
Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches.Cells. 2022 Mar 12;11(6):976. doi: 10.3390/cells11060976. Cells. 2022. PMID: 35326427 Free PMC article. Review.
References
-
- Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
